{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:15:03Z","timestamp":1789085703738,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Provincial Natural Science Foundation of China","award":["2023AF830"],"award-info":[{"award-number":["2023AF830"]}]},{"name":"Hubei Province Key Research and Development Project","award":["2020BCB025"],"award-info":[{"award-number":["2020BCB025"]}]},{"name":"Discipline and Platform Construction Project of Center for AIDS Research, Wuhan University","award":["PTPP2023002"],"award-info":[{"award-number":["PTPP2023002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003511"],"award-info":[{"award-number":["82003511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13866-7","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:55:04Z","timestamp":1782377704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of peripheral lymphocyte subsets in relation to opportunistic infections in people living with HIV\/AIDS"],"prefix":"10.1186","volume":"26","author":[{"given":"Rui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xien","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"23","key":"13866_CR1","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.3390\/molecules27238353","volume":"27","author":"ME Maffei","year":"2022","unstructured":"Maffei ME, Salata C, Gribaudo G. Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins. Molecules. 2022;27(23):8353.","journal-title":"Molecules"},{"issue":"1","key":"13866_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12916-022-02639-z","volume":"20","author":"E Haeuser","year":"2022","unstructured":"Haeuser E, Serfes AL, Cork MA, et al. Mapping age-and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000\u20132018. BMC Med. 2022;20(1):488.","journal-title":"BMC Med"},{"issue":"5","key":"13866_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/aid.2021.0085","volume":"38","author":"J Yan","year":"2022","unstructured":"Yan J, Luo L, Han J, et al. Comparing Noninvasive Predictors of Neurosyphilis Among Syphilis Patients With and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in China. AIDS Res Hum Retroviruses. 2022;38(5):406\u201314.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"13866_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/cid\/ciw139","volume":"62","author":"MR B-Lajoie","year":"2016","unstructured":"B-Lajoie MR, Drouin O, Bartlett G, et al. Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis. Clin Infect Dis. 2016;62(12):1586\u201394.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13866_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/infdis\/jiw085","volume":"214","author":"K Buchacz","year":"2016","unstructured":"Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000\u20132010. J Infect Dis. 2016;214(6):862\u201372.","journal-title":"J Infect Dis"},{"issue":"1","key":"13866_CR6","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1038\/s41598-019-39665-6","volume":"9","author":"YF Yen","year":"2019","unstructured":"Yen YF, Chen M, Jen IA, et al. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident opportunistic infections (OIs) among People Living with HIV\/AIDS. Sci Rep. 2019;9(1):3476.","journal-title":"Sci Rep"},{"issue":"2","key":"13866_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/17441692.2020.1805785","volume":"16","author":"J Renju","year":"2021","unstructured":"Renju J, Rice B, Songo J, et al. Influence of evolving HIV treatment guidance on CD4 counts and viral load monitoring: A mixed-methods study in three African countries. Glob Public Health. 2021;16(2):288\u2013304.","journal-title":"Glob Public Health"},{"issue":"10","key":"13866_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","volume":"24","author":"K Buchacz","year":"2010","unstructured":"Buchacz K, Baker RK, Palella FJ, et al. AIDS-defining opportunistic illnesses in US patients, 1994\u20132007: a cohort study. AIDS. 2010;24(10):1549\u201359.","journal-title":"AIDS"},{"issue":"18","key":"13866_CR9","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1097\/QAD.0b013e32834cdb4b","volume":"25","author":"J Reekie","year":"2011","unstructured":"Reekie J, Gatell JM, Yust I, et al. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. AIDS. 2011;25(18):2259\u201368.","journal-title":"AIDS"},{"issue":"1","key":"13866_CR10","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/s41598-022-10330-9","volume":"12","author":"DG Caetano","year":"2022","unstructured":"Caetano DG, Ribeiro-Alves M, Hottz ED, et al. Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals. Sci Rep. 2022;12(1):6569.","journal-title":"Sci Rep"},{"key":"13866_CR11","doi-asserted-by":"publisher","first-page":"829126","DOI":"10.3389\/fimmu.2022.829126","volume":"13","author":"LMS Pereira","year":"2022","unstructured":"Pereira LMS, Fran\u00e7a EDS, Costa IB, et al. HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil. Front Immunol. 2022;13:829126.","journal-title":"Front Immunol"},{"issue":"RR\u201311","key":"13866_CR12","first-page":"1","volume":"58","author":"GK Siberry","year":"2009","unstructured":"Siberry GK, Abzug MJ, Nachman S, et al. Guidelines for the Prevention and Treatment of OIs among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009;58(RR\u201311):1\u2013166.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"13866_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmi.2018.04.018","volume":"25","author":"J Jiang","year":"2019","unstructured":"Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV\/AIDS patients in southern China: a retrospective cohort study. Clin Microbiol Infect. 2019;25(2):233\u201341.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"13866_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/TP.0000000000001278","volume":"101","author":"R Arroyo Hornero","year":"2017","unstructured":"Arroyo Hornero R, Betts GJ, Sawitzki B, et al. CD45RA Distinguishes CD4\u2009+\u2009CD25+CD127-\/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. Transplantation. 2017;101(2):302\u20139.","journal-title":"Transplantation"},{"issue":"6","key":"13866_CR15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","volume":"35","author":"N Yu","year":"2012","unstructured":"Yu N, Li X, Song W, et al. CD4(+)CD25 (+)CD127 (low\/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35(6):1773\u201380.","journal-title":"Inflammation"},{"issue":"RR\u20134","key":"13866_CR16","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of OIs in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR\u20134):1\u2013CE4.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"13866_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/imm.12452","volume":"145","author":"E Papasavvas","year":"2015","unstructured":"Papasavvas E, Foulkes A, Yin X, et al. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1+patients. Immunology. 2015;145(3):380\u201390.","journal-title":"Immunology"},{"issue":"2","key":"13866_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4269\/ajtmh.12-0780","volume":"90","author":"M Okome-Nkoumou","year":"2014","unstructured":"Okome-Nkoumou M, Guiyedi V, Ondounda M, et al. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study. Am J Trop Med Hyg. 2014;90(2):211\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"13866_CR19","doi-asserted-by":"publisher","first-page":"16816","DOI":"10.1038\/s41598-020-73852-0","volume":"10","author":"NP Pm","year":"2020","unstructured":"Pm NP, Rg Z. The rapid CD4 + T-lymphocyte decline and human immunodeficiency virus progression in females compared to males. Sci Rep. 2020;10(1):16816. Published 2020 Oct 8.","journal-title":"Sci Rep"},{"issue":"7","key":"13866_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jmv.24177","volume":"87","author":"L Zhang","year":"2015","unstructured":"Zhang L, Huang Y, Liu Z, et al. Dynamics of T-cell subsets and their relationship with oral and systemic OIs in HIV\/AIDS patients during the first year of HAART in Guangxi, China. J Med Virol. 2015;87(7):1158\u201367.","journal-title":"J Med Virol"},{"key":"13866_CR21","doi-asserted-by":"publisher","first-page":"1269650","DOI":"10.3389\/fimmu.2023.1269650","volume":"14","author":"J Ma","year":"2023","unstructured":"Ma J, Wang G, Zhu X, et al. Combining CD4 count, CD8 count and CD4\/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis. Front Immunol. 2023;14:1269650.","journal-title":"Front Immunol"},{"issue":"5\u20136","key":"13866_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7883\/yoken.JJID.2003.187","volume":"56","author":"V Nissapatorn","year":"2003","unstructured":"Nissapatorn V, Lee C, Fatt QK, et al. AIDS-related OIs in Hospital Kuala Lumpur. Jpn J Infect Dis. 2003;56(5\u20136):187\u201392.","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"13866_CR23","first-page":"377","volume":"121","author":"N Kumarasamy","year":"2005","unstructured":"Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. Clinical profile of HIV in India. Indian J Med Res. 2005;121(4):377\u201394.","journal-title":"Indian J Med Res"},{"issue":"1","key":"13866_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcyt.2019.11.002","volume":"22","author":"C Evernden","year":"2020","unstructured":"Evernden C, Dowhan M, Dabas R, et al. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. Cytotherapy. 2020;22(1):27\u201334.","journal-title":"Cytotherapy"},{"issue":"3","key":"13866_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s42770-020-00277-2","volume":"51","author":"YH Chen","year":"2020","unstructured":"Chen YH, Fang XY, Li YT, et al. Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China. Braz J Microbiol. 2020;51(3):1061\u20139.","journal-title":"Braz J Microbiol"},{"key":"13866_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2018.06.010","volume":"134","author":"S Brakemeier","year":"2018","unstructured":"Brakemeier S, Pfau A, Zukunft B, et al. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61\u20137.","journal-title":"Pharmacol Res"},{"issue":"1","key":"13866_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","volume":"47","author":"MC Li","year":"2014","unstructured":"Li MC, Lee NY, Lee CC, et al. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect. 2014;47(1):42\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"13866_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","volume":"36","author":"N De Castro","year":"2005","unstructured":"De Castro N, Neuville S, Sarfati C, et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant. 2005;36(10):879\u201383.","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"13866_CR29","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1097\/QAD.0b013e32826fb6fc","volume":"21","author":"GE D\u2019Egidio","year":"2007","unstructured":"D\u2019Egidio GE, Kravcik S, Cooper CL, et al. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells\/\u00b5l when viral replication is suppressed. AIDS. 2007;21(13):1711\u20135.","journal-title":"AIDS"},{"issue":"1","key":"13866_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12981-021-00330-6","volume":"18","author":"L Lu","year":"2021","unstructured":"Lu L, Wang J, Yang Q, et al. The role of CD38 in HIV infection. AIDS Res Therapy. 2021;18(1):11.","journal-title":"AIDS Res Therapy"},{"issue":"1","key":"13866_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/cells10010174","volume":"10","author":"M Schank","year":"2021","unstructured":"Schank M, Zhao J, Moorman JP, et al. The Impact of HIV-and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging. Cells. 2021;10(1):174.","journal-title":"Cells"},{"issue":"2","key":"13866_CR32","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","volume":"140","author":"MJ Feinstein","year":"2019","unstructured":"Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019;140(2):e98\u2013124.","journal-title":"Circulation"},{"issue":"3","key":"13866_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/v11030200","volume":"11","author":"Zicari","year":"2019","unstructured":"Zicari. al \u2013\u20092019 - Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART. Viruses. 2019;11(3):200.","journal-title":"Viruses"},{"key":"13866_CR34","doi-asserted-by":"publisher","first-page":"1105432","DOI":"10.3389\/fimmu.2023.1105432","volume":"14","author":"K H\u00fclsk\u00f6tter","year":"2023","unstructured":"H\u00fclsk\u00f6tter K, L\u00fchder F, Leitzen E, et al. CD28-signaling can be partially compensated in CD28-knockout mice but is essential for virus elimination in a murine model of multiple sclerosis. Front Immunol. 2023;14:1105432.","journal-title":"Front Immunol"},{"issue":"8","key":"13866_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/cmi.2017.153","volume":"15","author":"X Chen","year":"2018","unstructured":"Chen X, Liu Q, Xiang AP. CD8\u2009+\u2009CD28- T cells: not only age-related cells but a subset of regulatory T cells. Cell Mol Immunol. 2018;15(8):734\u20136.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"13866_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.isci.2024.110947","volume":"27","author":"TS Kabakibo","year":"2024","unstructured":"Kabakibo TS, Arnold E, Padhan K, et al. Artificial antigen-presenting cell system reveals CD28\u2019s role in modulating T cell functions during human immunodeficiency virus infection. iScience. 2024;27(10):110\u2013947.","journal-title":"iScience"},{"issue":"3","key":"13866_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10238-015-0376-z","volume":"16","author":"HT Yu","year":"2016","unstructured":"Yu HT, Park S, Shin EC, Lee WW. T cell senescence and cardiovascular diseases. Clin Exp Med. 2016;16(3):257\u201363.","journal-title":"Clin Exp Med"},{"issue":"5","key":"13866_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou YA, Chopra G, et al. CD28 Costimulation: From Mechanism to Therapy. Immunity. 2016;44(5):973\u201388.","journal-title":"Immunity"},{"issue":"11","key":"13866_CR39","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/cells10112973","volume":"10","author":"S Ceeraz","year":"2021","unstructured":"Ceeraz S, Thompson CR, Beatson R, Choy EH. Harnessing CD8\u2009+\u2009CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease. Cells. 2021;10(11):2973.","journal-title":"Cells"},{"issue":"6","key":"13866_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0167-5699(91)90050-4","volume":"12","author":"AN Akbar","year":"1991","unstructured":"Akbar AN, Salmon M, Janossy G. The synergy between naive and memory T cells during activation. Immunol Today. 1991;12(6):184\u20138.","journal-title":"Immunol Today"},{"issue":"3","key":"13866_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2010.12.002","volume":"32","author":"A Guihot","year":"2011","unstructured":"Guihot A, Bourgarit A, Carcelain G, et al. Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol. 2011;32(3):131\u20137.","journal-title":"Trends Immunol"},{"issue":"22","key":"13866_CR42","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.4103\/0366-6999.193460","volume":"129","author":"FP Guo","year":"2016","unstructured":"Guo FP, Li YJ, Qiu ZF, et al. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters. Chin Med J (Engl). 2016;129(22):2683\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"12","key":"13866_CR43","doi-asserted-by":"publisher","first-page":"e0225415","DOI":"10.1371\/journal.pone.0225415","volume":"14","author":"V Bordoni","year":"2019","unstructured":"Bordoni V, Brando B, Piselli P, et al. Na\u00efve\/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study. PLoS ONE. 2019;14(12):e0225415.","journal-title":"PLoS ONE"},{"issue":"9672","key":"13866_CR44","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","volume":"373","author":"Timing of initiation of antiretroviral therapy","year":"2009","unstructured":"Timing of initiation of antiretroviral therapy. in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352\u201363.","journal-title":"Lancet"},{"key":"13866_CR45","doi-asserted-by":"crossref","unstructured":"Schacker TW, Bosch RJ, Bennett K, et al. Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. J Acquir Immune Defic Syndr. 2010;54(1):59\u201362.","DOI":"10.1097\/QAI.0b013e3181c96520"},{"issue":"2","key":"13866_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0b013e3181911991","volume":"50","author":"M Ding","year":"2009","unstructured":"Ding M, Tarwater P, Rodriguez M, et al. Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India. J Acquir Immune Defic Syndr. 2009;50(2):119\u201325.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"23","key":"13866_CR47","doi-asserted-by":"publisher","first-page":"13836","DOI":"10.1128\/JVI.01948-14","volume":"88","author":"SP Ribeiro","year":"2014","unstructured":"Ribeiro SP, Milush JM, Cunha-Neto E, et al. The CD8+ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection. J Virol. 2014;88(23):13836\u201344.","journal-title":"J Virol"},{"issue":"7","key":"13866_CR48","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, et al. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490\u2013500.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"13866_CR49","doi-asserted-by":"publisher","first-page":"e57336","DOI":"10.1371\/journal.pone.0057336","volume":"8","author":"A Horta","year":"2013","unstructured":"Horta A, Nobrega C, Amorim-Machado P, et al. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells. PLoS ONE. 2013;8(2):e57336.","journal-title":"PLoS ONE"},{"issue":"7","key":"13866_CR50","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.4049\/jimmunol.179.7.4323","volume":"179","author":"G Filaci","year":"2007","unstructured":"Filaci G, Fenoglio D, Fravega M, et al. CD8+CD28\u2013 T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers. J Immunol. 2007;179(7):4323\u201334.","journal-title":"J Immunol"},{"issue":"1","key":"13866_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1086\/523651","volume":"197","author":"S Smyk-Pearson","year":"2008","unstructured":"Smyk-Pearson S, Golden\u2010Mason L, Klarquist J, et al. Functional Suppression by FoxP3 + CD4 + CD25 high Regulatory T Cells during Acute Hepatitis C Virus Infection. J Infect Dis. 2008;197(1):46\u201357.","journal-title":"J Infect Dis"},{"issue":"1","key":"13866_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/QAI.0000000000000095","volume":"66","author":"A Weinberg","year":"2014","unstructured":"Weinberg A, Bosch R, Bennett K, et al. Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS. JAIDS J Acquir Immune Defic Syndr. 2014;66(1):25\u201332.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"13866_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/COH.0b013e328335c0c1","volume":"5","author":"B Kanwar","year":"2010","unstructured":"Kanwar B, Favre D, McCune JM. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS. 2010;5(2):151\u20137.","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"13866_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/QAD.0b013e3283344895","volume":"24","author":"A Prendergast","year":"2010","unstructured":"Prendergast A, Prado JG, Kang YH, et al. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS. 2010;24(4):491\u2013502.","journal-title":"AIDS"},{"issue":"5","key":"13866_CR55","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1128\/JVI.78.5.2454-2459.2004","volume":"78","author":"EM Aandahl","year":"2004","unstructured":"Aandahl EM, Micha\u00eblsson J, Moretto WJ, et al. Human CD4 + CD25 + Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens. J Virol. 2004;78(5):2454\u20139.","journal-title":"J Virol"},{"issue":"10","key":"13866_CR56","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1182\/blood-2004-01-0365","volume":"104","author":"L Weiss","year":"2004","unstructured":"Weiss L, Donkova-Petrini V, Caccavelli L, et al. Human immunodeficiency virus\u2013driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004;104(10):3249\u201356.","journal-title":"Blood"},{"issue":"3","key":"13866_CR57","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2005-02-0607","volume":"106","author":"H Nishikawa","year":"2005","unstructured":"Nishikawa H, J\u00e4ger E, Ritter G, et al. CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. Blood. 2005;106(3):1008\u201311.","journal-title":"Blood"},{"key":"13866_CR58","doi-asserted-by":"crossref","unstructured":"Vinhaes CL, Araujo-Pereira M, Tib\u00farcio R, et al. Systemic inflammation associated with immune reconstitution inflammatory syndrome in persons living with HIV. Life (Basel). 2021;11(1):65.","DOI":"10.3390\/life11010065"},{"issue":"1","key":"13866_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12981-021-00361-z","volume":"18","author":"MC Mueller","year":"2021","unstructured":"Mueller MC, Kern WV, Usadel S, et al. Assessing the differential impact of chronic CMV and treated HIV infection on CD8+ T-cell differentiation in a matched cohort study: is CMV the key? AIDS Res Ther. 2021;18(1):37.","journal-title":"AIDS Res Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13866-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13866-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:03:17Z","timestamp":1789084997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13866-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13866"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13866-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhongnan Hospital of Wuhan University, and all individuals signed an informed consent form.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1633"}}